Left Atrial Appendage (LAA) Closure Device Market to Develop Rapidly by 2026Posted by Mangesh on May 24th, 2019 The left atrial appendage (LAA) is a small, ear-shaped sac in the muscle wall of the left atrium (top left chamber of the heart). Functionally, when blood collects in the heart, it tends to pool in the LAA. The LAA closure is a minimally invasive procedure that is used to decrease the risk of stroke that may occur as a result of atrial fibrillation. Rise in prevalence of atrial fibrillation in geriatric population and technological advancements drive the global LAA closure device market. Furthermore, surge in government initiatives to raise public awareness related to cardiovascular diseases boosts the market growth. However, stringent government regulations towards LAA closure systems impede this growth. Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/3699 The global LAA closure device market is segmented on the basis of product, end user, and region. Based on product, it is bifurcated into epicardial and endocardial LAA closure devices. The end users are categorized into hospitals, ambulatory surgical centers, and heart clinics. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Comprehensive competitive analysis and profiles of major players, such as Boston Scientific Corporation, AtriCure, St. Jude Medical, Lifetech Scientific (Shenzhen), Coherex Medical, and Sentreheart, Inc., are provided in this report. Get a purchase enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/3699 Key Benefits:
Like it? Share it!More by this author |